Ali Sarfraz, Yin-Goen Qiqin, Johnson Timothy V, Han Wei, Johnson Nicole A, Harris Wayne B, Marshall Fray F, Young Andrew N, Master Viraj A, Osunkoya Adeboye O
Department of Pathology, Emory University School of Medicine, Room H174 1364 Clifton Road, NE Atlanta, GA 30322, USA.
Tumour Biol. 2011 Apr;32(2):375-80. doi: 10.1007/s13277-010-0130-9. Epub 2010 Nov 18.
C-reactive protein is produced in response to cytokines such as interleukin (IL)-6. It is known that increased plasma IL-6 levels induce increased hepatic and intratumoral production of C-reactive protein. Cyclooxygenase enzyme-2 is induced by various stimuli, including inflammation and various growth factors. Expression of these two markers has not been well studied in clear cell renal cell carcinoma. The objective of this study is to correlate the expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma with pathologic parameters. A search of the surgical pathology and consultation files at our institution was performed for nephrectomy specimens with clear cell renal cell carcinoma from 2007 to 2008. Immunohistochemical stains for C-reactive protein and cyclooxygenase enzyme-2 were performed. Staining intensity was graded as 0, 1+, 2+, and 3+. The staining intensity was then correlated with pathologic stage and Fuhrman nuclear grade for each case. A total of 110 cases were identified. Strong expression of C-reactive protein was associated with higher Fuhrman nuclear grade and pathologic stage, and the strength of correlation was statistically significant (p = 0.01 and p = 0.001), respectively. However, cyclooxygenase enzyme-2 expression did not show statistically significant correlation with both pathologic stage and Fuhrman nuclear grade (p = 0.1 and p = 0.15), respectively. To our knowledge, this is the largest study to date correlating the expression of both C-reactive protein and cyclooxygenase enzyme-2 in tissue with pathologic parameters in patients with clear cell renal cell carcinoma, which could have significant prognostic and therapeutic implications.
C反应蛋白是机体对诸如白细胞介素(IL)-6等细胞因子产生反应时所产生的。已知血浆IL-6水平升高会诱导肝脏和肿瘤内C反应蛋白的产生增加。环氧合酶-2可由多种刺激因素诱导产生,包括炎症和各种生长因子。在透明细胞肾细胞癌中,这两种标志物的表达尚未得到充分研究。本研究的目的是将透明细胞肾细胞癌中C反应蛋白和环氧合酶-2的表达与病理参数相关联。我们检索了本机构2007年至2008年期间行肾切除术的透明细胞肾细胞癌标本的外科病理和会诊档案。对C反应蛋白和环氧合酶-2进行免疫组织化学染色。染色强度分为0、1+、2+和3+级。然后将染色强度与每个病例的病理分期和Fuhrman核分级相关联。共鉴定出110例病例。C反应蛋白的强表达与较高的Fuhrman核分级和病理分期相关,且相关性强度具有统计学意义(p分别为0.01和0.001)。然而,环氧合酶-2的表达与病理分期和Fuhrman核分级均未显示出统计学意义的相关性(p分别为0.1和0.15)。据我们所知,这是迄今为止将组织中C反应蛋白和环氧合酶-2的表达与透明细胞肾细胞癌患者的病理参数相关联的最大规模研究,这可能具有重要的预后和治疗意义。